The government is set to approve remdesivir as a treatment for a new coronavirus infection as early as May (2020). Apply special measures to simplify the review process on the condition that it is approved overseas. Remdesivir, an intravenous drug developed by an American pharmaceutical company to treat Ebola hemorrhagic fever, is said to be used for people seriously ill with coronavirus, and is expected to be approved in Germany and the United States in the near future.
Avigan is only approved in China for the treatment of new coronavirus infections.
Remdesivir has been approved in the U.S. and Europe. Remdesivir is an intravenous infusion drug for critically ill people, and Avigan, a tablet drug used from the mild stage of illness, are different in terms of usability and use (Professor Okada).
The interests are glaring.
I hope they can use it as soon as possible.
